PTC Therapeutics, Inc.
US ˙ NasdaqGS ˙ US69366J2006

SecurityPTCT / PTC Therapeutics, Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership1,640,381 shares
Latest Disclosed Value $ 111,759,157
D. E. Shaw & Co., Inc. ownership in PTCT / PTC Therapeutics, Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 1,640,381 shares of PTC Therapeutics, Inc. (US:PTCT) valued at $111,759,158 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,744,991 shares of PTC Therapeutics, Inc.. This represents a change in shares of -5.99% during the quarter. The current value of the position is $112,661,367 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (PTCT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PTCT / PTC Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PTC THERAPEUTICS COM 69366J200 1,640,381 -104,610 -5.99 111,759 -15.68 0.0493
2026-02-17 2025-12-31 13F PTC THERAPEUTICS COM 69366J200 1,744,991 -429,617 -19.76 132,550 -0.68 0.0727
2025-11-14 2025-09-30 13F PTC THERAPEUTICS COM 69366J200 2,174,608 -263,089 -10.79 133,456 12.09 0.0753
2025-08-14 2025-06-30 13F PTC THERAPEUTICS COM 69366J200 2,437,697 992,418 68.67 119,057 61.65 0.0844
2025-05-15 2025-03-31 13F PTC THERAPEUTICS COM 69366J200 1,445,279 -97,013 -6.29 73,651 5.79 0.0656
2025-02-14 2024-12-31 13F PTC THERAPEUTICS COM 69366J200 1,542,292 122,753 8.65 69,619 32.19 0.0511
2024-11-14 2024-09-30 13F PTC THERAPEUTICS COM 69366J200 1,419,539 61,901 4.56 52,665 26.85 0.0452
2024-08-14 2024-06-30 13F PTC THERAPEUTICS COM 69366J200 1,357,638 131,890 10.76 41,517 16.43 0.0388
2024-05-15 2024-03-31 13F PTC THERAPEUTICS COM 69366J200 1,225,748 -121,219 -9.00 35,657 -3.95 0.0305
2024-02-14 2023-12-31 13F PTC THERAPEUTICS COM 69366J200 1,346,967 506,158 60.20 37,122 97.02 0.0324
2023-11-14 2023-09-30 13F PTC THERAPEUTICS COM 69366J200 840,809 107,821 14.71 18,843 -36.79 0.0197
2023-08-14 2023-06-30 13F PTC THERAPEUTICS COM 69366J200 732,988 27,470 3.89 29,811 -12.77 0.0305
2023-05-15 2023-03-31 13F PTC THERAPEUTICS COM 69366J200 705,518 -239,361 -25.33 34,175 -5.24 0.0366
2023-02-14 2022-12-31 13F PTC THERAPEUTICS COM 69366J200 944,879 -109,106 -10.35 36,066 -31.84 0.0399
2022-11-14 2022-09-30 13F PTC THERAPEUTICS COM 69366J200 1,053,985 101,198 10.62 52,910 38.62 0.0632
2022-08-15 2022-06-30 13F PTC THERAPEUTICS COM 69366J200 952,787 -84,603 -8.16 38,169 -1.38 0.0447
2022-05-16 2022-03-31 13F PTC THERAPEUTICS COM 69366J200 1,037,390 -157,590 -13.19 38,705 -18.68 0.0362
2022-02-14 2021-12-31 13F PTC THERAPEUTICS COM 69366J200 1,194,980 -4,553 -0.38 47,596 6.63 0.0395
2021-11-15 2021-09-30 13F PTC THERAPEUTICS COM 69366J200 1,199,533 -10,526 -0.87 44,635 -12.74 0.0403
2021-08-16 2021-06-30 13F PTC THERAPEUTICS COM 69366J200 1,210,059 41,004 3.51 51,149 -7.60 0.0441
2021-05-17 2021-03-31 13F PTC THERAPEUTICS COM 69366J200 1,169,055 195,412 20.07 55,354 -6.84 0.0534
2021-02-16 2020-12-31 13F PTC THERAPEUTICS COM 69366J200 973,643 94,172 10.71 59,421 44.52 0.0531
2020-11-16 2020-09-30 13F PTC THERAPEUTICS COM 69366J200 879,471 -15,096 -1.69 41,115 -9.42 0.0421
2020-08-14 2020-06-30 13F PTC THERAPEUTICS COM 69366J200 894,567 -101,403 -10.18 45,390 2.16 0.0541
2020-05-15 2020-03-31 13F PTC THERAPEUTICS COM 69366J200 995,970 -64,616 -6.09 44,430 -12.78 0.0693
2020-02-14 2019-12-31 13F PTC THERAPEUTICS COM 69366J200 1,060,586 248,942 30.67 50,940 85.57 0.0582
2019-11-14 2019-09-30 13F PTC THERAPEUTICS COM 69366J200 811,644 -25,578 -3.06 27,450 -27.14 0.0338
2019-08-14 2019-06-30 13F PTC THERAPEUTICS COM 69366J200 837,222 -45,414 -5.15 37,675 13.40 0.0470
2019-05-15 2019-03-31 13F PTC THERAPEUTICS COM 69366J200 882,636 -113,434 -11.39 33,223 -2.81 0.0429
2019-02-14 2018-12-31 13F PTC THERAPEUTICS COM 69366J200 996,070 -760,819 -43.30 34,185 -58.60 0.0471
2018-11-14 2018-09-30 13F PTC THERAPEUTICS COM 69366J200 1,756,889 -630,431 -26.41 82,574 2.54 0.0992
2018-08-14 2018-06-30 13F PTC THERAPEUTICS COM 69366J200 2,387,320 53,717 2.30 80,525 27.52 0.1050
2018-05-15 2018-03-31 13F PTC THERAPEUTICS COM 69366J200 2,333,603 -274,829 -10.54 63,147 45.14 0.0860
2018-02-14 2017-12-31 13F PTC THERAPEUTICS COM 69366J200 2,608,432 245,464 10.39 43,509 -7.98 0.0599
2017-11-14 2017-09-30 13F PTC THERAPEUTICS COM 69366J200 2,362,968 -358,707 -13.18 47,283 -5.22 0.0726
2017-08-14 2017-06-30 13F PTC THERAPEUTICS COM 69366J200 2,721,675 744,599 37.66 49,888 156.44 0.0825
2017-05-15 2017-03-31 13F PTC THERAPEUTICS COM 69366J200 1,977,076 474,164 31.55 19,454 18.64 0.0342
2017-02-14 2016-12-31 13F PTC THERAPEUTICS COM 69366J200 1,502,912 751,735 100.07 16,397 55.81 0.0279
2016-11-14 2016-09-30 13F PTC THERAPEUTICS COM 69366J200 751,177 722,416 2,511.79 10,524 5,109.90 0.0186
2016-08-15 2016-06-30 13F PTC THERAPEUTICS COM 69366J200 28,761 28,761 0.00 202 0.0004
2016-05-16 2016-03-31 13F PTC THERAPEUTICS COM 69366J200 0 -16,492 -100.00 0 -100.00
2016-02-16 2015-12-31 13F PTC THERAPEUTICS COM 69366J200 16,492 -37,593 -69.51 534 -63.02 0.0008
2015-11-16 2015-09-30 13F PTC THERAPEUTICS COM 69366J200 54,085 54,085 0.00 1,444 0.0021
2015-05-15 2015-03-31 13F PTC THERAPEUTICS COM 69366J200 0 -4,885 -100.00 0 -100.00
2015-02-17 2014-12-31 13F PTC THERAPEUTICS COM 69366J200 4,885 4,885 0.00 253 0.0003
2014-11-14 2014-09-30 13F PTC THERAPEUTICS COM 69366J200 0 -24,292 -100.00 0 -100.00
2014-08-14 2014-06-30 13F PTC THERAPEUTICS COM 69366J200 24,292 24,292 635 0.0009
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-11-14 2018-09-30 13F PTC THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F PTC THERAPEUTICS COM Call 54,000 -3.23 1,821 20.60 n/a n/a n/a
2018-05-15 2018-03-31 13F PTC THERAPEUTICS COM Call 55,800 1,510 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.